HSA
MRNA icon

HBK Sorce Advisory’s Moderna MRNA Stock Holding History

HBK Sorce Advisory’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,998
Closed -$359K – 757
2022
Q4 		$359K Buy
+1,998
New +$327K 0.01% 499
2022
Q2 		– Sell
-1,187
Closed -$204K – 524
2022
Q1 		$204K Sell
1,187
-747
-39% -$126K 0.01% 508
2021
Q4 		$491K Buy
1,934
+313
+19% +$91.5K 0.02% 336
2021
Q3 		$624K Sell
1,621
-98
-6% -$36.1K 0.03% 280
2021
Q2 		$404K Buy
1,719
+12
+0.7% +$2.15K 0.02% 366
2021
Q1 		$224K Buy
+1,707
New +$247K 0.01% 485
2020
Q4 		– Sell
-7,744
Closed -$548K – 508
2020
Q3 		$548K Sell
7,744
-3,510
-31% -$245K 0.04% 242
2020
Q2 		$723K Buy
+11,254
New +$616K 0.05% 198

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HBK Sorce Advisory's MRNA Position: Q1 2023 in Review

HBK Sorce Advisory sold out of Moderna (MRNA) in Q1 2023, closing a stake of 1,998 shares — an estimated $359K sold.

HBK Sorce Advisory first reported a position in MRNA in Q2 2020 and held it in 8 quarters. The position peaked at $723K in Q2 2020. 1,015 funds tracked by Wall St. Rank hold MRNA as of Q1 2023.

  • HBK Sorce Advisory reported no remaining Moderna position as of Q1 2023 after selling out during the quarter.
  • HBK Sorce Advisory sold 1,998 Moderna shares in Q1 2023, an estimated $359K.
  • HBK Sorce Advisory first reported a position in Moderna in Q2 2020 and held it in 8 quarters.
  • HBK Sorce Advisory's Moderna position peaked at $723K in Q2 2020.
  • 1,015 funds tracked by Wall St. Rank held Moderna as of Q1 2023.

Based on HBK Sorce Advisory's 13F filing for Q1 2023, filed 15 May 2023.